FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masanori Ito

Research Profile

Disorders

Living Beings

Helicobacter pylori

Chemicals & Drugs

Anatomy

Concepts & Ideas

Risk Factors

Procedures

Breath Tests

Co-author Network

Publications

TOP 3
Aki Tanaka; Jiro Hata; Kazuhiko Inoue; Masanori Ito; Tomoari Kamada; Hiroaki Kusunoki; Noriaki Manabe; Akiko Shiotani; Ken Haruma
Histological evaluation of patients with gastritis at high risk of developing gastric cancer using a conventional index.
Kuniaki Sugiu; Tomoari Kamada; Masanori Ito; S Kaya; Aki Tanaka; Hiroaki Kusunoki; Jiro Hata; Ken Haruma
Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
Kuniaki Sugiu; Tomoari Kamada; Masanori Ito; Shunji Kaya; Aki Tanaka; Hiroaki Kusunoki; Jiro Hata; Ken Haruma
Evaluation of an ELISA for detection of anti-parietal cell antibody.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masanori Ito (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Aki Tanaka; Jiro Hata; Kazuhiko Inoue; Masanori Ito; Tomoari Kamada; Hiroaki Kusunoki; Noriaki Manabe; Akiko Shiotani; Ken Haruma
Histological evaluation of patients with gastritis at high risk of developing gastric cancer using a conventional index.
Pathology, research and practice 2011;207(6):354-8.
2006: Kuniaki Sugiu; Tomoari Kamada; Masanori Ito; S Kaya; Aki Tanaka; Hiroaki Kusunoki; Jiro Hata; Ken Haruma
Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(5):303-7.
2006: Kuniaki Sugiu; Tomoari Kamada; Masanori Ito; Shunji Kaya; Aki Tanaka; Hiroaki Kusunoki; Jiro Hata; Ken Haruma
Evaluation of an ELISA for detection of anti-parietal cell antibody.
Hepato-gastroenterology 2006;53(67):11-4.
2005: Tomoari Kamada; Jiro Hata; Hiroaki Kusunoki; Kuniaki Sugiu; Masanori Ito; Shinji Tanaka; Yuzuru Kawamura; Kazuaki Chayama; Ken Haruma
Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
Alimentary pharmacology & therapeutics 2005;21 Suppl 2():99-104.
2005: Tomoari Kamada; Jiro Hata; Kuniaki Sugiu; Hiroaki Kusunoki; Masanori Ito; Shinji Tanaka; K Inoue; Yuzuru Kawamura; Kazuaki Chayama; Ken Haruma
Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan.
Alimentary pharmacology & therapeutics 2005;21(9):1121-6.
2005: Tomoari Kamada; Jiro Hata; Hiroaki Kusunoki; Masanori Ito; S Tanaka; Y Kawamura; Kazuaki Chayama; Ken Haruma
Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2005;37(1):39-43.
2003: Tomoari Kamada; Ken Haruma; Jiro Hata; Hiroaki Kusunoki; A Sasaki; Masanori Ito; Shinji Tanaka; Masaharu Yoshihara
The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.
Alimentary pharmacology & therapeutics 2003;18(2):245-52.
2003: Ken Haruma; Masanori Ito
Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide.
Alimentary pharmacology & therapeutics 2003;18 Suppl 1():153-9.
2003: Tomoari Kamada; Ken Haruma; Hiroaki Kusunoki; Masaki Miyamoto; Masanori Ito; Yasuhiko Kitadai; Masaharu Yoshihara; Kazuaki Chayama; Kazumasa Tahara; Yuzuru Kawamura
Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer.
Digestive diseases and sciences 2003;48(4):644-51.
2002: Ken Haruma; Masanori Ito; S Kido; Noriaki Manabe; Yasuhiko Kitadai; M Sumii; S Tanaka; Masaharu Yoshihara; Kazuaki Chayama
Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis.
Digestive diseases and sciences 2002;47(4):862-7.